
    
      A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Phase III Study to
      Investigate the Efficacy(Immunogenicity) and Safety of GC3110A(Quadrivalent Influenza
      Vaccine) After Intramuscular Administration in Healthy Subjects
    
  